Click the article below to learn more. HUMAN INTELLIGENCE – Meet the two teenagers (and a few others) who are using AI tech to tackle deadly glioblastoma. BE WELL – Here's the one easy thing you can do every day for heart health. VACCINE APPROVED – The FDA green-lights the first inoculation against RSV. The FDA has approved the first respiratory syncytial virus (RSV) vaccine for use in the U.S. (iStock) BACTERIAL OUTBREAK – Thirty-one patients are infected at one Seattle hospital.

Thomas Fuchs, the Dean of Artificial Intelligence and Human Health at Mount Sinai in NYC, said AI will be needed to retain the standard of care in the U.S. Glioblastoma is one of the deadliest types of brain cancer, with the average patient living only eight months after diagnosis, according to the National Brain Tumor Society, a nonprofit. Two ambitious high school students -- Andrea Olsen, 18, from Oslo, Norway, and Zachary Harpaz, 16, from Fort Lauderdale, Florida -- are looking to change that. The teens partnered with Insilico Medicine, a Hong Kong-based medical technology company, to identify three new target genes linked to glioblastoma and aging. They used Insilico's artificial intelligence platform, PandaOmics, to make the discovery -- and now, they plan to continue researching ways to fight the disease with new drugs. Their findings about target genes were published on April 26 in Aging, a peer-reviewed biomedical academic journal.